Inactive Instrument

Highlights Miromatrix Medical Inc.

Equities

MIRO

US60471P1084

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

United Therapeutics Corporation completed the acquisition of Miromatrix Medical Inc. from Gagnon Securities, LLC and others	13/12	CI
United Therapeutics, Miromatrix Medical Report Successful Tender Offer	12/12	MT
Miromatrix Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
United Therapeutics to Acquire Miromatrix Medical	30/23/30	MT
United Therapeutics To Acquire Miromatrix Medical	30/23/30	RE
Miromatrix Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Miromatrix Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
CareDx, Miromatrix Sign Exclusive Deal to Advance Research of Bioengineered Human Organs	05/23/05	MT
CareDx, Inc. and Miromatrix Medical Inc. Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation	05/23/05	CI
MIROMATRIX MEDICAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	01/23/01	AQ
Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update	01/23/01	GL
Miromatrix Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
Miromatrix Medical Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	01/23/01	CI
Miromatrix Medical Inc. and Baxter International Inc. Announces Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure	01/23/01	CI
Miromatrix Provides Update on miroliverELAP	01/23/01	CI
Miromatrix Medical's NDA for Acute Liver Failure Treatment Placed on 'Clinical Hold' -- Shares Drop After Hours	15/22/15	MT
Miromatrix Medical Inc. Announces FDA Clinical Hold on IND Application for miroliverELAP	15/22/15	CI
MIROMATRIX MEDICAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	15/22/15	AQ
Miromatrix Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Miromatrix Reports Filing of IND, Third Quarter 2022 Results, and Provides Corporate Update	15/22/15	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Miromatrix Medical Inc.

Equities

MIRO

US60471P1084

Highlights

Filters